Rankings
▼
Calendar
EW (Edwards Lifesciences Corporation) Stock Financials & Earnings | Market Cap Arena
EW
Edwards Lifesciences Corporation
Mkt Cap
$50B
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$6.1B
Net Income (TTM)
$1.1B
EPS (TTM)
$1.83
Free Cash Flow (TTM)
$1.3B
Gross Margin
78.1%
Op. Margin
26.7%
Net Margin
17.6%
FCF Margin
22.0%
P/S Ratio (TTM)
8.2x
P/E Ratio (TTM)
46.3x
YoY Rev Growth
+11.2%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$1.5B
$1.1B
$403M
Q2 23
$1.3B
$1.0B
$371M
Q3 23
$1.2B
$971M
$347M
Q4 23
$1.3B
$1.0B
$357M
Q1 24
$1.3B
$1.0B
$356M
Q2 24
$1.4B
$1.1B
$365M
Q3 24
$1.4B
$1.1B
$351M
Q4 24
$1.4B
$1.1B
$313M
Q1 25
$1.4B
$1.1B
$395M
Q2 25
$1.5B
$1.2B
$431M
Q3 25
$1.6B
$1.2B
$425M
Q4 25
$1.6B
$1.2B
$370M
marketcaparena.com
Revenue Breakdown
EW
Edwards Lifesciences Corporation
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
9.0x
33.3x
Q2 23
9.1x
35.7x
Q3 23
9.3x
34.7x
Q4 23
9.4x
35.4x
Q1 24
9.7x
35.1x
Q2 24
9.5x
33.7x
Q3 24
9.3x
11.9x
Q4 24
9.1x
11.9x
Q1 25
9.0x
11.9x
Q2 25
8.7x
12.0x
Q3 25
8.4x
36.3x
Q4 25
8.2x
46.3x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$314M
$253M
Q2 23
$34M
-$14M
Q3 23
$412M
$356M
Q4 23
$137M
$35M
Q1 24
-$54M
-$139M
Q2 24
$372M
$286M
Q3 24
$352M
$320M
Q4 24
-$128M
-$177M
Q1 25
$280M
$224M
Q2 25
$290M
$241M
Q3 25
$574M
$516M
Q4 25
$451M
$354M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$62M
Q2 23
$48M
Q3 23
$55M
Q4 23
$102M
Q1 24
$85M
Q2 24
$85M
Q3 24
$32M
Q4 24
$50M
Q1 25
$56M
Q2 25
$49M
Q3 25
$58M
Q4 25
$97M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+8.8%
+16.7%
Q2 23
-5.7%
-2.2%
Q3 23
-5.7%
+0.6%
Q4 23
-6.1%
-3.1%
Q1 24
-8.9%
-7.8%
Q2 24
+7.0%
+10.4%
Q3 24
+8.9%
+11.9%
Q4 24
+9.4%
+18.0%
Q1 25
+6.2%
+4.5%
Q2 25
+10.6%
+7.8%
Q3 25
+14.7%
+12.4%
Q4 25
+13.3%
+11.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$39M
2.7%
Q2 23
$37M
2.9%
Q3 23
$33M
2.6%
Q4 23
$31M
2.4%
Q1 24
$45M
3.4%
Q2 24
$44M
3.2%
Q3 24
$42M
3.1%
Q4 24
$51M
3.7%
Q1 25
$40M
2.8%
Q2 25
$38M
2.4%
Q3 25
$41M
2.7%
Q4 25
$39M
2.5%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$261M
$436M
Q2 23
$244M
$410M
Q3 23
$243M
$382M
Q4 23
$242M
$417M
Q1 24
$257M
$428M
Q2 24
$273M
$451M
Q3 24
$253M
$421M
Q4 24
$271M
$492M
Q1 25
$255M
$466M
Q2 25
$276M
$502M
Q3 25
$281M
$515M
Q4 25
$268M
$603M
marketcaparena.com
Revenue Segments
Critical Care
Surgical Heart Valve Therapy
Transcatheter Heart Valves
Transcatheter Mitral And Tricuspid Therapies
Quarter
Critical Care
Surgical Heart Valve Therapy
Transcatheter Heart Valves
Transcatheter Mitral And Tricuspid Therapies
Q1 23
$222M
$248M
$948M
$42M
Q2 24
—
$264M
$1.0B
$83M
Q3 24
—
$240M
$1.0B
$91M
Q4 24
—
$211M
$1.0B
$105M
Q1 25
—
$251M
$1.0B
$115M
Q2 25
—
$267M
$1.1B
$135M
Q3 25
—
$258M
$1.1B
$145M
Q4 25
—
$254M
$1.2B
$156M
marketcaparena.com
Revenue by Geography
Europe
Japan
Rest of World
United States
Quarter
Europe
Japan
Rest of World
United States
Q1 23
$331M
$114M
$165M
$849M
Q2 24
$336M
$87M
$146M
$817M
Q3 24
$320M
$81M
$149M
$805M
Q1 25
$342M
$82M
$150M
$839M
Q2 25
$378M
$95M
$169M
$890M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$873M
$382M
$1.3B
Q2 23
$1.0B
$467M
$1.5B
Q3 23
$1.4B
$454M
$1.9B
Q4 23
$1.1B
$501M
$1.6B
Q1 24
$1.2B
$473M
$1.7B
Q2 24
$1.6B
$345M
$2.0B
Q3 24
$3.7B
$770M
$4.4B
Q4 24
$3.0B
$931M
$4.0B
Q1 25
$3.1B
$758M
$3.9B
Q2 25
$3.3B
$789M
$4.1B
Q3 25
$2.7B
$1.2B
$3.8B
Q4 25
$2.9B
$1.3B
$4.2B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
611M
-0.9%
Q2 23
610M
-0.1%
Q3 23
610M
-0.1%
Q4 23
607M
-0.4%
Q1 24
604M
-0.5%
Q2 24
604M
+0.0%
Q3 24
598M
-1.0%
Q4 24
591M
-1.3%
Q1 25
588M
-0.5%
Q2 25
588M
+0.0%
Q3 25
586M
-0.4%
Q4 25
582M
-0.7%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$255K
9K
FY 15
$254K
10K
FY 16
$267K
11K
FY 17
$282K
12K
FY 18
$291K
13K
FY 19
$313K
14K
FY 20
$294K
15K
FY 21
$333K
16K
FY 22
$311K
17K
FY 23
$253K
20K
FY 24
$344K
16K
FY 25
$379K
16K
marketcaparena.com